Seres Therapeutics (MCRB) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Seres Therapeutics (MCRB) over the last 10 years, with Q3 2025 value amounting to 0.0.
- Seres Therapeutics' Asset Utilization Ratio rose 85546.1% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year increase of 85546.1%. This contributed to the annual value of 0.36 for FY2023, which is 166286.38% up from last year.
- According to the latest figures from Q3 2025, Seres Therapeutics' Asset Utilization Ratio is 0.0, which was up 85546.1% from 0.0 recorded in Q3 2024.
- In the past 5 years, Seres Therapeutics' Asset Utilization Ratio registered a high of 0.47 during Q3 2021, and its lowest value of 0.0 during Q3 2024.
- Its 5-year average for Asset Utilization Ratio is 0.22, with a median of 0.22 in 2021.
- Within the past 5 years, the most significant YoY rise in Seres Therapeutics' Asset Utilization Ratio was 172210.69% (2024), while the steepest drop was 9992.28% (2024).
- Over the past 5 years, Seres Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.39 in 2021, then tumbled by 94.41% to 0.02 in 2022, then skyrocketed by 1525.37% to 0.35 in 2023, then crashed by 99.93% to 0.0 in 2024, then surged by 855.46% to 0.0 in 2025.
- Its Asset Utilization Ratio was 0.0 in Q3 2025, compared to 0.0 in Q3 2024 and 0.0 in Q2 2024.